Proteasome Inhibitors Market

The market for proteasome inhibitors is experiencing rapid transformation. Amgen’s acquisition of Onyx Pharmaceuticals, developer of Kyprolis, for $10.4 billion comes just five years after Takeda paid $8.8 billion for Millennium Pharmaceuticals, developer of Velcade, the first in class.

US Colony Stimulating Factors Market

The US market for colony stimulating factors, which currently stands at $4.5 billion, is about to face a major upheaval, with windows of opportunities openning for innovative pharma and biotech companies.

Transcatheter Aortic Valves Market 2014

The global transcatheter aortic heart valves market is expected to surpassed $1 billion in 2013 and shows strong signs of continued growth. Interventional cardiologists are exceptionally enthusiastic about the potential of the technology and clinical data continue to show improvement.

Amgen: Rheumatoid Arthritis & Psoriasis Medication Enbrel US Sales Forecast

The Pharmaceutical Strategist has released its updated US sales forecast for Amgen’s TNF receptor fusion protein Enbrel (etanercept), currently indicated for the treatment of moderate to severe active rheumatoid arthritis, active psoriatic arthritis, active ankylosing spondylitis and chronic moderate to severe plaque psoriasis.

Johnson & Johnson: Biological Psoriasis Therapeutic Stelara Sales Forecast

The Pharmaceutical Strategist has released its updated global sales forecast for Johnson & Johnson’s Psoriasis medication Stelara (ustekinumab), currently approved in 74 countries for plaque psoriasis and received both FDA and European approval for psoriatic arthritis in September 2013.

Johnson & Johnson: TNF inhibitor Remicade US Sales Forecast

The Pharmaceutical Strategist has released its updated US sales forecast for Johnson & Johnson’s TNF inhibitor Remicade (infliximab), currently indicated for the treatment of psoriasis, Crohn's disease, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis.

AbbVie: TNF Antagonist Humira US Sales Forecast

Pharmaceutical Strategist has released its updated US sales forecast for AbbVie’s TNF Antagonist Humira (adalimumab), the third TNF inhibitor, after infliximab and etanercept, to be approved in the United States. Like infliximab and etanercept, adalimumab binds to Tumor necrosis factor-alpha (TNF╬▒), preventing it from activating TNF receptors.

US Anti-Depressant Market

At 270 million prescriptions per year, anti-depressants are the most consumed class of therapeutics in the US. However, sales revenue does not match prescription numbers.

US Neurovascular Intervention Market

The US Neurovascular Intervention Market is expected to grow at an average annual growth rate of 6% over the next five years with thrombectomy devices, aneurysm stents and flow diversion devices offering above average growth.

Medullary Thyroid Carcinoma Market

Recent advances in genetic testing have revolutionized the management of medullary thyroid cancer (MTC) and lead to the approval of a new class of small molecule tyrosine kinase inhibitors which can combat dysregulated tyrosine kinases at various steps in the activation pathway.

Global Automotive Embedded Telematics Market

The Global Automotive Embedded Telematics market, which has been witnessing a decrease in theaverage price of original equipment manufacturer’s automotive embedded telematics equipments, is experiencing increase in demand and is expected to grow at a CAGR of 36% over the next five years.

Global Automatic Data Capture Market

Increase in the need for accuracy in data computation coupled with recent introduction of of multipurpose mobile computers are driving growth in the Automatic Data Capture market, which is expected to grow at a CAGR of 12% over the next five years.

Global Advanced Driver Assistance Systems Market

The Global Advanced Driver Assistance Systems (ADAS) market is forecast to grow at the annual rate of 23% over the next five year with increasing adoption of safety features and measures contributing to this above average growth.

Global Building Integrated Photovoltaics Market

The Global Market for Building Integrated Photovoltaics is forecast to grow at an average annual rate of 17% over the next five years with the increasing number of facilities available to store solar energy the main growth contributor.

Global 2D Gesture Recognition Market

The Global 2D Gesture Recognition market is forecast to grow at a CAGR of 26% over the next five years. One of the key factors contributing to this market growth is the need for cost-effective gesture recognition solutions.

Global Enterprise Network Security Market

The Global Enterprise Network Security market is forecast to grow at a CAGR of 7% over the next five years with the growing virtualization of servers as one of the main contributors to growth.

U.S. Memory Foam Mattress Market

The U.S. Memory Foam Mattress market is expected to grow at a CAGR of 12% over the next five years with the introduction of plant-based memory foam mattresses and the increase in incidence of sleep disorders contributing to growth.

Global Sleep Apnea Diagnostic and Therapeutic Devices Market

The Global Sleep Apnea Diagnostic and Therapeutic Devices market is expected to grow at a CAGR of 16% over the next five years. Increase in the adoption of home diagnostic devices coupled with an increase in incidence of sleep apnea are two of the factors contributing to growth.

Global Fiber Laser Market

The Global Fiber Laser market is expected to grow at a CAGR of 23% over the next five years with increase in adoption a key deriving factor. Manufacturers have also been increase their R&D spending recently.

Global Mobile Satellite Services Market

The Global Mobile Satellite Service market is expected to grow at a CAGR of 10% over the next five years with increase in the demand for broadband mobile satellite services as the main contributing factor to growth.

Global Mobile Computing Devices Market

Mobile computing devices have made headway in the Electronics industry in the last decade. Devices such as smartphones and tablets have become indispensable to most people across the globe.